MDS Pharma Services to Focus on the Delivery of Early Stage Services - Discovery Through Phase IIa TORONTO, July 1 /PRNewswire-FirstCall/ -- MDS...
New Partnership Seeks to Strengthen Fragile Medical Isotope Supply Chain OTTAWA, June 15 /PRNewswire-FirstCall/ -- MDS Nordion, a leading global...
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule...
TORONTO, June 11 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life...
Bracco's Cardiogen-82(R) Enables Cardiologists to Better Detect Cardiovascular Disease OTTAWA, June 10 /PRNewswire-FirstCall/ -- MDS Nordion, a...
Investment Supports and Reflects Contract Research Organization's Recently Announced Strategic Focus on Discovery Through Phase IIa Services KING...
TORONTO, June 4 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life...
OTTAWA, June 1 /PRNewswire-FirstCall/ -- MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, today urged the...
Applied Biosystems, a division of Life Technologies Corporation (NASDAQ:LIFE), and its mass spectrometry joint-venture partner...
Company to Divest Late Stage Operations, Signs Agreement to Sell Phase II-IV Operations to INC Research TORONTO, June 1 /PRNewswire-FirstCall/...
OTTAWA, Canada and FLEURUS, Belgium, May 28 /PRNewswire-FirstCall/ -- - Site to Provide Fluorodeoxyglucose (F-18 FDG) for use in Earlier...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.